Home›Companies›Healthcare›Aveera Medical

Aveera Medical Inc.

Develops an investigational catheter for doctors treating patients at risk of limb amputation.

Updated Nov 11, 2026·Latest SEC filing Feb 26, 2026·Suggest an edit

About Aveera Medical

Aveera Medical is a private company based in San Clemente, California. It has reported $8,821,502 raised in two offerings on Form D since April 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 16, 2026Feb 26, 2026$5,351,737of $5.3M target89$60,132EquityRule 506(b)Form D ↗
Mar 22, 2024Apr 4, 2024$3,469,765of $7.5M target60$57,829EquityRule 506(b)Form D ↗
Total, two offerings$8,821,502

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aveera Medical's Form D filed Feb 26, 2026.

SP
Steve Parker
Director
Also a director at Ellipsys Medical.
BD
Brian Driscoll
President
Also CEO and director at Ellipsys Medical.
JS
Joseph Steele
Executive officer, director and promoter
EC
Ed Chang
Director
Also a director at Ellipsys Medical.
MR
Mark Ritchart
Director
Also a director at Ellipsys Medical.
JH
Jeffrey Hull
Director
Also a director at Ellipsys Medical.

Sources

  1. SECAveera Medical Inc. filing history
  2. ResearchFDA 510(k) summary